Rinvoq (upadacitinib) - AbbVie
Rinvoq: Newly added patents in Orange Book (Orange Book) - Sep 18, 2019 - Expiry of patents on December 1, 2030, January 15, 2031, October 17, 2036 
Patent
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
 
Sep 18, 2019
 
 
ad85586a-c513-430e-ac2e-84110ee47fbc.jpg